Dusseldorf - Delayed Quote EUR
CytomX Therapeutics Inc (6C1.DU)
1.8920
+0.0940
+(5.23%)
At close: May 16 at 7:31:54 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-81,229
-86,231
-56,035
-110,788
-119,031
Investing Cash Flow
85,411
99,700
-150,674
98,260
22,489
Financing Cash Flow
7,348
7,522
30,230
648
110,213
End Cash Position
48,632
39,079
18,088
194,567
206,447
Income Tax Paid Supplemental Data
--
--
--
--
0
Capital Expenditure
-314
-310
-840
-1,740
-1,609
Issuance of Capital Stock
--
6,909
--
0
107,712
Free Cash Flow
-81,543
-86,541
-56,875
-112,528
-120,640
12/31/2021 - 8/19/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
N04.SG Nucana PLC (ADRs)
0.0320
+3.23%
N04.MU Nucana PLC R
0.0475
+6.74%
N04.F NuCana plc
0.0390
+30.00%
2LB.BE Iovance Biotherapeutics Inc
1.5646
+4.06%
N04.BE Nucana PLC R
0.0825
-2.37%
NXTC NextCure, Inc.
0.4380
+5.98%
ASMB Assembly Biosciences, Inc.
13.42
+7.36%
REVB Revelation Biosciences, Inc.
3.0500
-0.97%
GLYC GlycoMimetics, Inc.
0.2470
-1.12%
GLPG.AS Galapagos NV
24.40
+2.01%